The Biden administration announced plans to spend billions of dollars to ramp up United States vaccine production.
Officials said on Nov. 17 that the Department of Health and Human Services (HHS) will reach out to mRNA vaccine manufacturers to identify opportunities to scale up production with the goal of increasing capacity to a billion doses per year starting in the second half of 2022.
